Spectrum Wealth Counsel »

Crispr Therapeutics shares owned by Spectrum Wealth Counsel

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Spectrum Wealth Counsel from 13F filings

Historical chart of Spectrum Wealth Counsel investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Spectrum Wealth Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Spectrum Wealth Counsel

Quarter filed Position value Share count Share price at filing
2024-09-30 $188 4 47.00
2024-06-30 $217 4 54.25
2024-03-31 $273 4 68.25
2023-12-31 $25k 404 62.60